ArticleCureus2026
Obstructive Sleep Apnea in Patients With and Without Diabetic Retinopathy: An Observational Study and Comparative Analysis.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Obstructive sleep apnea (OSA) causes intermittent hypoxia that may amplify retinal ischemia, accelerating the onset and progression of diabetic retinopathy (DR), specifically proliferative diabetic retinopathy (PDR). This study investigates the association between OSA and DR, including PDR, in an Indian cohort of type 2 diabetes mellitus (T2DM) patients. Methods In a prospective observational study conducted from October 2022 to December 2023 at a tertiary care centre, 85 T2DM patients (45 with DR, 40 without DR) underwent OSA screening using the Epworth Sleepiness Scale (ESS). High-risk patients (ESS ≥10) underwent polysomnography (PSG), with OSA severity graded by Apnea-Hypopnea Index (AHI). Results High OSA risk significantly correlated with longer diabetes duration (p=0.033), elevated HbA1c (p=0.030), dyslipidemia (p=0.003), hypertension (p=0.005), neck circumference (p=0.02), and BMI (p<0.001). DR prevalence was higher in high-risk OSA patients (58.33% vs. 52.05%, p=0.686), with a trend toward PDR (57.14% vs. 42%, p=0.943). PSG in nine patients revealed a trend showing greater oxygen desaturation index (ODI) and AHI in the DR group, albeit without statistical significance (p>0.05). Conclusion Though OSA association with DR and PDR remains statistically inconclusive, the results are exploratory and hypothesis-generating. Screening for OSA in resource-limited, busy DR clinics can detect additional risk factors. The novel AHI-sleep parameter trends advocate for further studies to validate OSA as a modifiable risk factor.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.